Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner
Kanae Yumimoto, … , Koshi Mimori, Keiichi I. Nakayama
Kanae Yumimoto, … , Koshi Mimori, Keiichi I. Nakayama
Published January 2, 2015
Citation Information: J Clin Invest. 2015;125(2):621-635. https://doi.org/10.1172/JCI78782.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 24

F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner

  • Text
  • PDF
Abstract

The gene encoding F-box protein FBXW7 is frequently mutated in many human cancers. Although most previous studies have focused on the tumor-suppressive capacity of FBXW7 in tumor cells themselves, we determined that FBXW7 in the host microenvironment also suppresses cancer metastasis. Deletion of Fbxw7 in murine BM-derived stromal cells induced accumulation of NOTCH and consequent transcriptional activation of Ccl2. FBXW7-deficient mice exhibited increased serum levels of the chemokine CCL2, which resulted in the recruitment of both monocytic myeloid-derived suppressor cells and macrophages, thereby promoting metastatic tumor growth. Administration of a CCL2 receptor antagonist blocked the enhancement of metastasis in FBXW7-deficient mice. Furthermore, in human breast cancer patients, FBXW7 expression in peripheral blood was associated with serum CCL2 concentration and disease prognosis. Together, these results suggest that FBXW7 antagonizes cancer development in not only a cell-autonomous manner, but also a non-cell-autonomous manner, and that modulation of the FBXW7/NOTCH/CCL2 axis may provide a potential approach to suppression of cancer metastasis.

Authors

Kanae Yumimoto, Sayuri Akiyoshi, Hiroki Ueo, Yasuaki Sagara, Ichiro Onoyama, Hiroaki Ueo, Shinji Ohno, Masaki Mori, Koshi Mimori, Keiichi I. Nakayama

×

Total citations by year

Year: 2025 2023 2022 2021 2020 2019 2018 2017 2016 2015 Total
Citations: 2 8 7 7 10 5 7 12 4 6 68
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (68)

Title and authors Publication Year
Disrupting EDEM3‐induced M2‐like macrophage trafficking by glucose restriction overcomes resistance to PD‐1/PD‐L1 blockade
Peng S, Wu M, Yan Q, Xu G, Xie Y, Tang G, Lin J, Yuan Z, Liang X, Yuan Z, Weng J, Bai L, Wang X, Yu H, Huang M, Luo Y, Liu X
Clinical and Translational Medicine 2025
The FBXW7–KMT2 axis in cancer-associated fibroblasts controls tumor growth via an epigenetic-paracrine mechanism
Yin L, Zhang J, Zhu Z, Peng X, Lan H, Ayoub A, Tan M, Zhou B, He Y, Wang S, Lu Y, Liu W, Xiong X, Huang J, Dou Y, Mao F, Sun Y
Proceedings of the National Academy of Sciences of the United States of America 2025
FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy
Chen S, Lin J, Zhao J, Lin Q, Liu J, Wang Q, Mui R, Ma L
Frontiers in Oncology 2023
Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis.
Li Y, Li M, Su K, Zong S, Zhang H, Xiong L
Theranostics 2023
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.
Yoshimura T, Li C, Wang Y, Matsukawa A
Cellular & molecular immunology 2023
The Role of FBXW7 in Gynecologic Malignancies
Di Fiore R, Suleiman S, Drago-Ferrante R, Subbannayya Y, Suleiman S, Vasileva-Slaveva M, Yordanov A, Pentimalli F, Giordano A, Calleja-Agius J
Cells 2023
KPNA2 Silencing, Regulated by E3 Ubiquitin Ligase FBXW7, Alleviates Endothelial Dysfunction and Inflammation Through Inhibiting the Nuclear Translocation of p65 and IRF3: A Possible Therapeutic Approach for Atherosclerosis.
Xing Z, Zhen Y, Chen J, Du M, Li D, Liu R, Zheng J
Inflammation 2023
FBXW7 in breast cancer: mechanism of action and therapeutic potential.
Chen S, Leng P, Guo J, Zhou H
Journal of experimental & clinical cancer research : CR 2023
Epigenetic Status of FBXW7 Gene and Its Role in Ovarian Cancer Pathogenesis
Al Hinai M, Malgundkar SH, Gupta I, Lakhtakia R, Al Kalbani M, Burney I, Al Moundhri M, Okamoto A, Tamimi Y
Asian Pacific Journal of Cancer Prevention 2023
The role of germanium in diseases: exploring its important biological effects
Luo X, Sun J, Kong D, Lei Y, Gong F, Zhang T, Shen Z, Wang K, Luo H, Xu Y
Journal of Translational Medicine 2023
Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets
A Karagiannakos, M Adamaki, A Tsintarakis, B Vojtesek, R Fåhraeus, V Zoumpourlis, K Karakostis
Cancers 2022
Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations
H Thirmanne, F Wu, D Janssens, J Swanger, A Diab, H Feldman, R Amezquita, R Gottardo, P Paddison, S Henikoff, B Clurman
eLife 2022
Clinical significance of FBXW7 loss of function in human cancers
J Fan, M Bellon, M Ju, L Zhao, M Wei, L Fu, C Nicot
Molecular Cancer 2022
Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Pu Y, Ji Q
Frontiers in immunology 2022
Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
Xing L, Xu L, Zhang Y, Che Y, Wang M, Shao Y, Qiu D, Yu H, Zhao F, Zhang J
Frontiers in Oncology 2022
The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression.
Xia L, Chen J, Huang M, Mei J, Lin M
Frontiers in Oncology 2022
Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.
Kawaguchi Y, Ohshio Y, Watanabe A, Shiratori T, Okamoto K, Ueda K, Kataoka Y, Suzuki T, Hanaoka J
Cancer Science 2022
The FBXW7‐NOTCH interactome : A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues
R Kar, SK Jha, S Ojha, A Sharma, S Dholpuria, VS Raju, P Prasher, DK Chellappan, G Gupta, S Singh, KR Paudel, PM Hansbro, S Singh, J Ruokolainen, KK Kesari, K Dua, NK Jha
EMBO reports 2021
The Role of Macrophages in Cancer Development and Therapy
E Cendrowicz, Z Sas, E Bremer, TP Rygiel
Cancers 2021
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
YH Huang, K Cai, PP Xu, L Wang, CX Huang, Y Fang, S Cheng, XJ Sun, F Liu, JY Huang, MM Ji, WL Zhao
Signal Transduction and Targeted Therapy 2021
FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2
F Xu, J Li, M Ni, J Cheng, H Zhao, S Wang, X Zhou, X Wu
Molecular Cancer 2021
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
W Zhao, J Liu, Y Li, Z Chen, D Qi, Z Zhang
Frontiers in pharmacology 2021
Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
H Wang, J Pan, L Barsky, J Jacob, Y Zheng, C Gao, S Wang, W Zhu, H Sun, L Lu, H Jia, Y Zhao, C Bruns, R Vago, Q Dong, L Qin
2021
F-box and WD repeat domain-containing 7 (FBXW7) mediates the hypoxia inducible factor-1α (HIF-1α)/vascular endothelial growth factor (VEGF) signaling pathway to affect hypoxic-ischemic brain damage in neonatal rats
L Sun
Bioengineered 2021
Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer
D Zeng, Z Ye, J Wu, R Zhou, X Fan, G Wang, Y Huang, J Wu, H Sun, M Wang, J Bin, Y Liao, N Li, M Shi, W Liao
Theranostics 2020
Notch-Inflammation Networks in Regulation of Breast Cancer Progression
Y Liubomirski, A Ben-Baruch
Cells 2020
Drug repositioning in cancer: The current situation in Japan
T Masuda, Y Tsuruda, Y Matsumoto, H Uchida, KI Nakayama, K Mimori
Cancer Science 2020
STYX/FBXW7 axis participates in the development of endometrial cancer cell via Notch–mTOR signaling pathway
L Liu, H Jiang, X Wang, X Wang, L Zou
Bioscience Reports 2020
F-Box Proteins and Cancer
K Yumimoto, Y Yamauchi, KI Nakayama
Cancers 2020
Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma
Y Zheng, A Song, C Wang, W Zhang, D Liang, X Ding, G Li, H Zhang, W Zhang, Y Du, J Zhou, H Wu, Y Wu, X Song
Cell Death and Disease 2020
Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
T Masuda, M Noda, T Kogawa, D Kitagawa, N Hayashi, T Jomori, Y Nakanishi, KI Nakayama, S Ohno, K Mimori
Cancer Science 2020
E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc
L Zhong, Y Zhang, M Li, Y Song, D Liu, X Yang, D Yang, H Qu, L Lai, Q Wang, Z Chen
Aging 2020
Function and regulation of F‑box/WD repeat‑containing protein 7 (Review)
Z Zhang, Q Hu, W Xu, W Liu, M Liu, Q Sun, Z Ye, G Fan, Y Qin, X Xu, X Yu, S Ji
Oncology Letters 2020
Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans
S Sinha, K Mitchell, A Zingone, E Bowman, N Sinha, A Schäffer, J Lee, E Ruppin, B Ryan
2020
Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells
Hideyuki Shimizu, Shoichiro Takeishi, Hirokazu Nakatsumi, Keiichi Nakayama
JCI Insight 2019
Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma
I Vázquez-Domínguez, L González-Sánchez, P López-Nieva, P Fernández-Navarro, M Villa-Morales, MÁ Cobos-Fernández, I Sastre, MF Fraga, AF Fernández, M Malumbres, M Salazar-Roa, O Graña-Castro, J Santos, P Llamas, JL López-Lorenzo, J Fernández-Piqueras
Oncogene 2019
FBXW7 in Cancer: What Has Been Unraveled Thus Far?
BL Sailo, K Banik, S Girisa, D Bordoloi, L Fan, CE Halim, H Wang, AP Kumar, D Zheng, X Mao, G Sethi, AB Kunnumakkara
Cancers 2019
Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
K Yumimoto, S Sugiyama, K Mimori, KI Nakayama
Cancer Science 2019
Fbxw7 and Skp2 Regulate Stem Cell Switch between Quiescence and Mitotic Division in Lung Adenocarcinoma
W Zhang, Z Ren, L Jia, X Li, X Jia, Y Han
BioMed Research International 2019
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
M Colombo, L Mirandola, M Chiriva-Internati, A Basile, M Locati, E Lesma, R Chiaramonte, N Platonova
Frontiers in immunology 2018
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses
F Hossain, S Majumder, DA Ucar, PC Rodriguez, TE Golde, LM Minter, BA Osborne, L Miele
Frontiers in immunology 2018
Emerging roles of Myc in stem cell biology and novel tumor therapies
GJ Yoshida
Journal of Experimental & Clinical Cancer Research 2018
Notch Signaling in Macrophages in the Context of Cancer Immunity
T Palaga, W Wongchana, P Kueanjinda
Frontiers in immunology 2018
FBXW7: a critical tumor suppressor of human cancers
CH Yeh, M Bellon, C Nicot
Molecular Cancer 2018
Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
ED Francesco, M Maggiolini, A Musti
International journal of molecular sciences 2018
Prognostic values of F-box members in breast cancer: an online database analysis and literature review
X Wang, T Zhang, S Zhang, J Shan
Bioscience Reports 2018
Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis
P Chen, H Zuo, H Xiong, MJ Kolar, Q Chu, A Saghatelian, DJ Siegwart, Y Wan
Proceedings of the National Academy of Sciences 2017
Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model
A Nabeshima, J Pajarinen, T Lin, X Jiang, E Gibon, LA Córdova, F Loi, L Lu, E Jämsen, K Egashira, F Yang, Z Yao, SB Goodman
Biomaterials 2017
Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells
K Osanai, Y Kobayashi, M Otsu, T Izawa, K Sakai, M Iwashita
Human Cell 2017
Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells
D Bauer, N Redmon, E Mazzio, KF Soliman, A Ahmad
PloS one 2017
Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer
E Stankiewicz, X Mao, DC Mangham, L Xu, M Yeste-Velasco, G Fisher, B North, T Chaplin, B Young, Y Wang, JK Bansal, S Kudahetti, L Spencer, CS Foster, H Møller, P Scardino, RT Oliver, J Shamash, J Cuzick, CS Cooper, DM Berney, YJ Lu
Scientific Reports 2017
Molecular genetics complexity impeding research progress in breast and ovarian cancers
I Gupta, I Burney, MS Al-Moundhri, Y Tamimi
Molecular and Clinical Oncology 2017
Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression
E Ratovitski
Current genomics 2017
Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer
Y Wang, P Zhang, Y Wang, P Zhan, C Liu, JH Mao, G Wei
Cancer research 2017
Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer
Y Takano, T Masuda, H Iinuma, R Yamaguchi, K Sato, T Tobo, H Hirata, Y Kuroda, S Nambara, N Hayashi, T Iguchi, S Ito, H Eguchi, T Ochiya, K Yanaga, S Miyano, K Mimori
Oncotarget 2017
miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells
G Xiao, B Zhang, J Meng, J Wang, C Xu, SC Tang, X Li, J Zhang, R Liang, H Ren, X Sun
Cell cycle (Georgetown, Tex.) 2017
Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients
Y Shinden, K Sugimachi, F Tanaka, K Fujiyoshi, Y Kijima, S Natsugoe, K Mimori
Molecular and Clinical Oncology 2017
[Effects of myeloid specific deficiency of FBXW7 on lung metastasis of murine melanoma].
Wei Z, Lihua L, Qingqing W
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2017
Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma
T Kodama, JY Newberg, M Kodama, R Rangel, K Yoshihara, JC Tien, PH Parsons, H Wu, MJ Finegold, NG Copeland, NA Jenkins
Proceedings of the National Academy of Sciences 2016
Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer
H Bi, T Tian, L Zhu, H Zhou, H Hu, Y Liu, X Li, F Hu, Y Zhao, G Wang
Scientific Reports 2016
Clinical and biological significance of circulating tumor cells in cancer
T Masuda, N Hayashi, T Iguchi, S Ito, H Eguchi, K Mimori
Molecular Oncology 2016
miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients’ Susceptibility to Liver Metastasis
T Iguchi, S Nambara, T Masuda, H Komatsu, M Ueda, S Kidogami, Y Ogawa, Q Hu, K Sato, T Saito, H Hirata, S Sakimura, R Uchi, N Hayashi, S Ito, H Eguchi, K Sugimachi, Y Maehara, K Mimori, A Ahmad
PloS one 2016
MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7
X Zhou, W Jin, H Jia, J Yan, G Zhang
Journal of Experimental & Clinical Cancer Research 2015
Fbxw7 suppresses cancer metastasis by inhibiting niche formation
K Yumimoto, KI Nakayama
OncoImmunology 2015
Therapeutic strategies targeting cancer stem cells
GJ Yoshida, H Saya
Cancer Science 2015
Function analysis of rs9589207 polymorphism in miR-92a in gastric cancer
C Liu, Y Zhang, H Chen, L Jiang, D Xiao
Tumor Biology 2015
Transcriptional regulation of myeloid-derived suppressor cells
T Condamine, J Mastio, DI Gabrilovich
Journal of leukocyte biology 2015
F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression
X Tian, S Dai, J Sun, G Jin, S Jiang, F Meng, Y Li, D Wu, Y Jiang
Oncotarget 2015

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 9 X users
Referenced in 2 patents
On 2 Facebook pages
Referenced in 2 Wikipedia pages
Mentioned in 1 Google+ posts
82 readers on Mendeley
See more details